Background and Purpose-Long-term survival in patients after carotid endarterectomy (CEA) is determined mainly by their concomitant cardiac disease. We tested to determine whether preoperative thallium scanning (PTS) and subsequent selective coronary revascularization (CR), by either percutaneous transluminal coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG), improve long-term survival after CEA. Methods-Two hundred twenty-six of 255 consecutive patients (88%) undergoing CEA from 1990 to 1996 had PTS. Those with significant reversible defects on PTS were referred for coronary angiography and possible CR. Patients who had undergone PTS were divided into the following 4 groups: group 1, normal or mild defects on PTS; group 2, moderate-severe fixed and/or reversible defects in patients who did not undergo CR; group 3, patients who had CR secondary to their PTS results; and group 4, patients who had CR in the past that was not related to the PTS. Perioperative data were prospectively recorded, and data on long-term survival and cardiac and neurological complications were collected. Results-Seventy-seven patients (34%) had preoperative coronary angiography, and 42 (19%) had subsequent CR:
S ince the publication of the multicenter, randomized studies demonstrating the superiority of carotid endarterectomy (CEA) over medical treatment in long-term stroke prevention in patients with carotid stenosis, 1-3 the indications for CEA have increased and the number of patients referred for CEA has been growing. Although neurological outcome is markedly improved by CEA, long-term morbidity and mortality in patients with significant carotid stenosis are still heavily influenced by their concomitant cardiac disease. Candidates for CEA have Ͼ20% mortality from cardiacrelated causes within 4 years, whether or not they undergo CEA. 3 Patients with known or silent coronary artery disease (CAD) and those who are unable to exercise experience the worst long-term cardiac morbidity and mortality rates. 4 Based on these data, several investigators have contended that candidates for CEA may benefit from an intensive preoperative cardiac workup to detect and treat high-risk cardiac patients. [5] [6] [7] Until 1993, 50% to 75% of patients undergoing major vascular surgery in the United States had at least 1 of the following preoperative tests performed: exercise ECG testing, thallium scintigraphy, stress echocardiography, or ambulatory ischemia monitoring. 8 In light of the current low perioperative complication rates (Ͻ3%) and the doubts raised about the accuracy of thallium testing in predicting perioperative cardiac complications, it has become difficult to demonstrate any significant beneficial effects from pre-CEA routine cardiac testing and coronary revascularization (CR) on perioperative outcome. 9 In addition, cost-containment trends in medical care and the current guidelines of the American College of Cardiology/American Heart Association 9 tend to reduce the use of preoperative cardiac testing. However, the question of whether patients who undergo CEA should have cardiac screening for the purpose of assessing their long-term outcome has been raised previously by authors 10, 11 but has failed to generate adequate answer. In the present study we examined the effect of preoperative thallium testing and selective perioperative CR on long-term survival after CEA.
Subjects and Methods
We studied 255 patients who underwent 288 consecutive CEA procedures at Hadassah University Hospital in Jerusalem, Israel, from 1990 to 1996. Two hundred forty-five patients had 278 CEA procedures (32 patients had bilateral CEAs, and 1 had bilateral CEAs and a repeat unilateral CEA); 10 patients were admitted for CEA, but because of the results of the preoperative cardiac evaluation were referred for combined CEA and coronary artery bypass grafting (CABG). The indications for CEA were (1) an angiographic finding of Ͼ70% stenosis (diameter reduction on angiography) of the internal carotid artery in patients with ipsilateral neurological symptoms, ie, cerebrovascular accident, transient ischemic attack, or amaurosis fugax during the last 6 months before surgery, or (2) an angiographic finding of Ͼ80% internal carotid artery stenosis in patients who were neurologically asymptomatic in the previous 6 months.
It was our policy during these years to perform preoperative thallium scanning (PTS) on patients scheduled for CEA, in addition to the routine testing, clinical history, physical examination, 12-lead ECG and chest x-ray. Thallium scanning was performed in all patients except: 1) Patients with previously known coronary lesions, ie, those who had coronary angiography within the last year and who had no subsequent change in cardiac symptoms; 2) Patients who were referred from other institutions with a negative regular exercise stress test and no history of ischemic heart disease 3) patients who required urgent CEA due to crescendo transient ischemic attacks.
Depending on their ability to exercise, patients were stressed by upright treadmill exercise according to the Bruce protocol, or by dipyridamole infusion (0.56 mg/Kg BW over 4 minutes) immediately followed by 3 min of isometric hand grip exercise. Two mCi of thallium-201 were given at peak exercise, and immediate, and 4 hours delayed SPECT images were obtained. 12 An additional 1.0 mCi of thallium was given prior to the delayed images. Thallium defects were defined as either fixed or reversible, depending on whether they persisted on the delayed images or improved, respectively. Defect size was determined based on a 9 sector model of the heart: the anterior, lateral, inferior and posterior walls each divided in to basal and apical regions, plus the apex. A defect larger than 2 sectors was defined as large, 1 to 2 sectors was moderate size and Ͻ 1 was small size defect. Defect severity was evaluated based on the ratio of defect intensity to presumed normal myocardial area: mild defect -a reduction ofՅ25 to 40% in counts, moderate -40% to 50% reduction, and severe -Ն 50% reduction in counts at the defect compared with the normal area. Patients with moderate to severe reversible defects or multiple areas of reversible defects on thallium images were referred to coronary angiography and possible CR by either percutaneous transluminal coronary angioplasty (PTCA) or CABG prior to the CEA, combined CEAϩCABG or CABG after the CEA (staged procedure). Preoperative PTCA was performed for technically accessible significant (Ͼ70%) coronary lesions. CABG was preferred in patients with severe triple-vessel CAD or a left main coronary lesion. CABG prior to CEA was done only during the years 1990 to 1992 since combined CEAϩCABG procedures were initiated at our institution during 1992 and were the preferred mode of treatment for patients with severe combined disease thereafter. None of the patients admitted for CEA during the study period was excluded from surgery due to the cardiac disease.
All preoperative clinical findings and perioperative data, including postoperative cardiac or neurological complications were recorded prospectively. Preoperative history of ischemic heart disease (IHD) was defined as clinical evidence of myocardial infarction, angina pectoris, or CR at any time in the past. History of neurological symptoms was recorded if the patient had experienced a cerebrovascular accident, transient ischemic attack, or amaurosis fugax at any time in the past (on any side). Lower-extremity arterial disease was considered present if a patient had intermittent claudication, ischemic pain at rest, or a foot ulcer or gangrene due to peripheral arterial disease.
Patients were monitored perioperatively for any sign or symptom of a cardiac or neurological event. Routine 12-lead ECG and serum creatine kinase-MB isoenzymes were obtained on the first, second, and third postoperative days, and later if clinically indicated.
All preoperative 12-lead ECGs were analyzed retrospectively by 2 independent investigators for signs of pathological Q waves, voltage criteria for left ventricular hypertrophy, baseline ST depression (Ն0.5 mm), or T-wave inversion, based on the Sokolow-Lyon Criteria for left ventricular hypertrophy, 13 as previously published. 14 All preoperative thallium results, coronary angiograms, or PTCA and CABG data were retrieved from the hospital's computerized registry.
Long-term follow-up data, including death, cause of death, and neurological and cardiac complications, were collected using 3 complementary methods. (1) Patient charts were reviewed for hospitalizations and visits to outpatient clinics. Two hundred five of the patients (80.3%) had visited Hadassah's outpatient clinics during the 6 months preceding the end of the follow-up period. (2) All but 6 surviving patients (97.1%) were interviewed by phone for their cardiac and neurological symptoms. (3) For patients who died, date and cause of death were obtained by reviewing death certificates from the Ministry of Interior Affairs. Cardiac death was defined as death following myocardial infarction, congestive heart failure, or fatal arrhythmia. Late cardiac event was defined as hospitalization for myocardial infarction, congestive heart failure, unstable angina, PTCA, or CABG.
To examine the effect of selective perioperative CR on long-term survival, patients were divided into 4 non-overlapping groups: group 1, patients with normal scans or mild (fixed or reversible) thallium defects, with no CR in their past; group 2, patients with moderatesevere (fixed or reversible) thallium defects who did not undergo CR; group 3, patients with moderate-severe thallium defects who had perioperative CR based on their thallium findings; and group 4), patients with moderate-severe thallium defects who had CR at any time in the past, not related to the preoperative thallium testing.
Statistical Analyses
Student's t test and 2 analyses were used to compare continuous and dichotomous variables between groups of patients, respectively. The Kaplan-Meier method, log-rank test, and Cox (univariate and multivariate) regression model were used to identify predictors for long-term survival. The forced-entry method was used for variable selection by the Cox regression model to get the maximal number of predictors of long-term survival.
Results
Preoperative demographic and clinical details of all patients are found in Table 1 . The results of preoperative thallium testing and subsequent coronary angiography and revascularization procedures are summarized in Table 2 . Of the 102 (45.1%) patients who had moderate to severe reversible defects or partially redistributing multiple fixed defects on thallium scanning, 77 (75.5%) had findings considered sig-nificant enough to require preoperative coronary angiography. After coronary angiography, 42 patients had perioperative CR. Preoperative cardiac catheterizations and CRs in the entire group were not associated with periprocedural mortality. There were no major perioperative complications from either the PTCA or the CABG procedures. After combined CEAϩCABG, 1 patient had a prolonged ICU stay because of sepsis and multiorgan failure, and another patient underwent re-exploration because of bleeding and cardiac tamponade.
Intraoperative carotid shunting was used in 28% of the patients, and a synthetic patch was used for carotid closure in 72% of the patients. Table 3 shows the perioperative and late morbidity and mortality rates. Follow-up duration of all survivors was 40.6Ϯ23.5 months (range, 2 to 103 months; interquartile,: 19 to 59 months).
Predictors of Long-Term Outcome
Diabetes mellitus, abnormal preoperative 12-lead ECG results (in particular, inverted T waves), preoperative neurological symptoms, lower-extremity vascular disease, and history of IHD were the independent predictors of long-term survival (Tables 4 and 5 and Figure 1 ). Diabetes mellitus, history of IHD, and lower-extremity arterial disease were the only independent predictors of long-term cardiac morbidity (myocardial infarction, congestive heart failure, unstable angina pectoris, PTCA, or CABG) by multivariate analysis [exp(␤)ϭ2.54, 2.50, and 1.91; Pϭ0.0004, 0.01 and 0.03, respectively].
Thallium Testing and Perioperative Coronary Revascularization
The 226 patients who had preoperative thallium testing were divided into the following 4 groups: group 1, 117 patients with normal or mild defects on preoperative thallium testing and no previous revascularization; group 2, 41 patients with moderate-to-severe fixed and/or reversible defects who did not undergo CR; group 3, 42 patients who had perioperative CR as a result of the thallium testing; and group 4, 26 patients who had undergone CR in the past that was not related to the preoperative thallium testing. Nineteen of these patients had †Includes all strokes both ipsilateral and contralateral to the CEA as well as strokes from other territories (cerebellar/occipital).
moderate-to-severe (mostly fixed) thallium defects, and 7 had either normal scans or mild perfusion defects.
Using Kaplan-Meier life-table analysis ( Figure 2 ) patients in group 2 had significantly worse overall and cardiac long-term survival compared with group 1, (Log-rankϭ6.97 and 11.5, and Pϭ0.008 and 0.0008, respectively). Moreover, group 2 had a worse long-term overall and cardiac survival than group 3 (log rankϭ4.97 and 5.41 and Pϭ0.02 and 0.06, respectively). group 4 had worse cardiac survival than group 1 (Pϭ0.04). By adding this grouping into the multivariate Cox regression analysis together with other independent predictors of survival (except for preoperative ECG), only group 2 was independently associated with long-term cardiac mortality (Table 5) .
Patients in group 3 were not significantly different from those in group 2 in terms of preoperative clinical predictors except for higher incidences of history of ischemic heart disease (mainly history of angina pectoris), left bundlebranch block by ECG, and a higher rate of preoperative coronary angiography in group 3 (Table 6 ). Twenty-one 
Discussion
This study shows that the main negative predictors of long-term survival after CEA are diabetes mellitus, preoperative 12-lead ECG abnormalities (T-wave inversion in particular), lower-extremity vascular disease, and preoperative neurological symptoms. In addition, PTS independently predicts long-term cardiac survival. Moderate-to-severe (fixed and/or reversible) defects are associated with a 2.8-fold increase in cardiac mortality if not treated by CR. Finally, long-term survival of patients who undergo CR based on PTS is similar to that of patients with normal scans or mild preoperative thallium defects and significantly better than that of patients with moderate-to-severe thallium defects who do not undergo CR.
Hertzer et al 15 were the first to establish that cardiac disease plays a central role in morbidity and mortality of CEA patients. They routinely performed preoperative coronary angiography and showed that 37% of patients suspected of having CAD and 16% of those with no history of CAD had surgically correctable coronary lesions. Cardiac complications accounted for most early, as well as late, deaths following CEA, and long-term survival in their study was significantly improved in patients who underwent CABG based on preoperative coronary angiograms. 16 Subsequent Figure 2 . Kaplan-Meier survival functions of the 4 groups of patients who had PTS. Group 1: 117 patients with normal scans or mild defects on thallium scanning. Group 2: 41 patients who had moderate-to-severe fixed and/or reversible preoperative thallium defects but did not undergo CR. Group 3: 42 patients who underwent perioperative CR secondary to moderate-tosevere defects on PTS findings. Group 4: patients who had CR at any time in the past that was not related to the PTS. Group 2 had significantly worse long-term overall and cardiac survival rates compared with group 1 (Pϭ0.009 and Pϭ0.002, respectively) and also compared with group 3 (Pϭ0.02 and Pϭ0.06, respectively). Group 4 had worse cardiac survival rates than group 1 (Pϭ0.04). investigations confirmed that CAD rather than cerebrovascular disease is the most frequent cause of morbidity and mortality after CEA. 6, 17 Subgroups of patients without overt CAD but with diabetes mellitus, peripheral vascular disease, abnormal preoperative ECG, or coexisting intracranial occlusive disease also exhibit long-term cardiac survival as reduced as that of patients with overt CAD. 9, 18 In accordance with the findings of Hertzer et al, 29 (25%: 15 CABG and 14 PTCA) of our patients with and 13 (11.8%: 5 CABG and 8 PTCA) of those without symptomatic IHD had CR, although in our series these were based on preoperative thallium testing rather than routine coronary angiography. Our data also agree with the reports showing that preoperative clinical factors other than overt IHD, such as diabetes mellitus, ECG abnormality, and symptomatic lowerextremity vascular disease, are stronger predictors of longterm outcome than a clinical history of IHD, despite the fact that most (66%) late deaths are of cardiac origin. Our study, however, expands previous observations by underscoring the impact of PTS and selective CR on long-term survival following CEA.
In the present cohort study, 88% of the patients had preoperative thallium testing. One third of them had subsequent coronary angiography, and 54.5% of those who had coronary angiography were treated perioperatively by either PTCA (52.4%) or CABG (47.6%). Few studies report data on selective coronary angiography and revascularization after PTS. Most of the data are derived from patients undergoing a variety of vascular surgical procedures rather than only CEA. 19 -21 In those studies, coronary angiography was performed in 7.5% to 35% of the patients studied by thallium imaging. Coronary revascularization, however, was performed in only 15% to 36% of those who had coronary angiography. Massie et al 20 contended that coronary angiography did not provide any additional useful information for most peripheral vascular surgery patients with abnormal thallium scanning; this was due to their poor coronary anatomy, which was not suitable for revascularization. In contrast, in our study a relatively high proportion of the patients had CRs. This proportion is almost identical to that (55%) predicted on theoretical grounds by Mason et al 22 from the high sensitivity and specificity of thallium testing in detecting CAD and the estimated feasibility of CR in vascular surgery patients. Mason et al also predicted that 50% of the patients could be revascularized by PTCA. The difference between our data and those of Massie et al 20 may reflect the fact that the prevalence of correctable CAD is different in CEA and lower-extremity arterial bypass patients, 23 although other factors, such as differences in views of the treating clinicians about which coronary vessels can be revascularized, could contribute to the difference between the 2 studies.
Thallium SPECT scanning has a high sensitivity (87% to 98%) and a good specificity (56% to 91%) for detection of CAD 24 and is a well known predictor of long-term cardiac morbidity and mortality. 25 In our study also, thallium scanning was an independent predictor of long-term cardiac mortality in patients not treated by CR (Table 5) . Furthermore, our study is the first to show that selective CR guided by routine thallium testing significantly improves long-term survival in patients undergoing CEA. Survival after perioperative CR resembled that of patients with normal or mild thallium abnormality and was significantly better than that of patients with moderate-to-severe thallium defects who did not undergo such revascularization (Figure 2) . CABG is known to improve long-term survival in both moderate-and high-risk cardiac patients (risk defined by number of diseased vessels and presence of left ventricular dysfunction). 26 PTCA and CABG confer similar long-term survival rates in patients with multivessel coronary disease, although PTCA requires more subsequent coronary interventions than CABG. 27, 28 In the present study, CR based on routine thallium testing in CEA patients improved long-term survival even though the CR group (group 3) included patients with single-and double-vessel as well as multivessel coronary disease. It is possible, therefore, that preoperative thallium testing and CR initiated a track of better cardiac follow-up and repeated CRs in patients in whom revascularizations were feasible, which then contributed to the better survival of these patients.
Should all patients undergoing CEA have PTS? Our data agree with those of previous publications that routine preoperative thallium testing is not indicated solely for the purpose of stratifying and lowering perioperative cardiac risk. We do show, however, that the mere fact that a patient is a candidate for carotid surgery is an indication for more intensive cardiac screening, such as thallium scanning, because CR based on such testing can improve the patient's long-term survival. Thallium scanning may be performed preoperatively whereas CR, if indicated, can be done before, after, or even during the same surgery, according to each patient's risks and benefits. Moreover, 93% of the patients who underwent perioperative CR (group 3) had at least 1 of the following findings: history of ischemic heart disease, abnormal preoperative ECG abnormality, diabetes mellitus, and symptomatic lower-extremity vascular disease. Patients without these findings (26% of all our patients) had an excellent long-term survival ( Figure 1 ) and could probably be spared the preoperative thallium testing. The remaining 74% of the patients are those who benefited most from the preoperative cardiac screening. In contrast, testing only patients with a history of ischemic heart disease (47% of our patients) would result in the detection of only 69% of the cases with correctable CAD.
Study Limitations
PTS was used as part of our routine cardiac assessment strategy and not as a study protocol. This investigation is therefore a case series and not a case-control study. Consequently, groups 2 and 3, which form the core of the study, may not be entirely comparable because patients were not randomly assigned to either group but rather selected by the cardiology consultants on the basis of on their thallium imaging and angiography results. Group 3 contained the highest-risk patients who were selected for revascularization. Group 2 also included patients with mainly fixed defects but also patients in whom CR was theoretically indicated but not performed because of technical considerations of feasibility of the procedures. Both groups were comparable, however, in terms of their other preoperative clinical predictors, except for the higher incidence of overt ischemic heart disease in group 3.
We conclude that coronary angiography and revascularization based on preoperative thallium dipyridamole scanning can be safely performed in CEA patients by tailoring the right type and timing of revascularization to each patient's coronary anatomy and overall risk. Such CR, if performed before, during, or after operation, significantly improves patients' long-term survival. Further prospective randomized studies are needed to confirm our findings.
